Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

Senate Appropriations Subcommittee Calls for 40% Increase in Funding for Alzheimer’s Research

Cure Alzheimer’s Fund is thankful to the Senate Appropriations Subcommittee for their support of increasing vital funding for Alzheimer’s disease research with the NIH. With a $400 million increase, the proposed budget for Alzheimer’s research at the NIH will reach close to $1.4 billion, nearly triple what it was three years ago, demonstrating the understanding in Congress of the need to continue to fund research to address the disease.

Henry McCance Joins Jeff Morby as a Co-Chair of the Board of Directors of the Cure Alzheimer’s Fund

Jeff Morby and Henry McCance have been named Co-Chairs of Cure Alzheimer's Fund's Board of Directors.

New Study: Abeta Related to Innate Immunity, Raising New Questions about the Role of Infection in Alzheimer’s Disease

Research suggests Abeta is an antimicrobial peptide and that infection may trigger plaque buildup in the brains of Alzheimer’s patients.

Research Consortium Annual Meeting

This year, the Cure Alzheimer’s Fund Research Consortium had its annual meeting in San Diego to discuss and debate the latest research progress. About 15 scientists attended, along with the entire CAF board and key staff members. “The group’s discussion was wide ranging and spirited,” said Meg Smith, CAF’s senior advisor for strategy and special projects. Consortium members asked each other tough questions, talked through future implications, and shared prepublication data, which rarely happens in the world of science.

Cure Alzheimer’s Fund Partnering with Maria Shriver and Equinox Sports Clubs for MOVE FOR MINDS Experience on May 21st

Cure Alzheimer’s Fund will partner with Maria Shriver and Equinox Sports Clubs for the MOVE FOR MINDS Experience on May 21st. 100 percent of the donations generated from this experience will go to partner organizations of The Women's Alzheimer's Challenge, of which Cure Alzheimer’s Fund is a part.

Rudy Tanzi, Ph.D., Creates App for Alzheimer's Patients

Cure Alzheimer's Fund Research Consortium Chair Rudy Tanzi, Ph.D., has assisted in the creation of a new mobile app for Alzheimer's patients and caregivers, called SPARK Memories Radio.

Tim Armour Pens Op-Ed for Huffington Post

In a recent op-ed piece for Huffington Post Science, Cure Alzheimer’s Fund president and CEO Tim Armour makes the case for optimism regarding Alzheimer’s research.

Featured Researcher: Wilma Wasco, Ph.D.

When Wilma Wasco accidentally cloned an amyloid precursor-like protein as a post-doctorate fellow, she began her lifelong career studying Alzheimer’s disease.

Genes to Therapies: One Year Later

In just its first year of operation, Cure Alzheimer’s Fund’s ambitious new Genes to Therapies™ (G2T) research program has bloomed far beyond expectations.

“We’re firing on all cylinders now,” says Research Consortium Chair Dr. Rudy Tanzi. “It’s exactly where we need to be headed to stop this disease.”

U.S. Government Increases Support of Alzheimer’s Research

Cure Alzheimer's Fund is very appreciative of the continuing commitment of Congress and President Obama reaffirmed by the approval of increased funding for Alzheimer's disease research. The additional $350 million for NIH included in the tax and spending bill signed into law is a tremendous step toward the $2 billion a year experts, including members of the Cure Alzheimer's Fund Research Consortium, have said is necessary to effectively treat or prevent Alzheimer's disease by 2025.